1. Home
  2. VRAX vs REBN Comparison

VRAX vs REBN Comparison

Compare VRAX & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • REBN
  • Stock Information
  • Founded
  • VRAX 2013
  • REBN 2015
  • Country
  • VRAX United Kingdom
  • REBN United States
  • Employees
  • VRAX N/A
  • REBN N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • REBN Restaurants
  • Sector
  • VRAX Health Care
  • REBN Consumer Discretionary
  • Exchange
  • VRAX Nasdaq
  • REBN Nasdaq
  • Market Cap
  • VRAX 7.3M
  • REBN 18.5M
  • IPO Year
  • VRAX 2022
  • REBN 2022
  • Fundamental
  • Price
  • VRAX $1.90
  • REBN $4.01
  • Analyst Decision
  • VRAX
  • REBN
  • Analyst Count
  • VRAX 0
  • REBN 0
  • Target Price
  • VRAX N/A
  • REBN N/A
  • AVG Volume (30 Days)
  • VRAX 282.7K
  • REBN 7.3M
  • Earning Date
  • VRAX 02-05-2025
  • REBN 03-27-2025
  • Dividend Yield
  • VRAX N/A
  • REBN N/A
  • EPS Growth
  • VRAX N/A
  • REBN N/A
  • EPS
  • VRAX N/A
  • REBN N/A
  • Revenue
  • VRAX $84,872.00
  • REBN $5,502,528.00
  • Revenue This Year
  • VRAX $5,169.18
  • REBN $185.18
  • Revenue Next Year
  • VRAX $66.97
  • REBN $64.55
  • P/E Ratio
  • VRAX N/A
  • REBN N/A
  • Revenue Growth
  • VRAX 7.03
  • REBN 9.70
  • 52 Week Low
  • VRAX $0.60
  • REBN $0.92
  • 52 Week High
  • VRAX $9.00
  • REBN $8.80
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 49.13
  • REBN 59.65
  • Support Level
  • VRAX $1.58
  • REBN $3.64
  • Resistance Level
  • VRAX $2.10
  • REBN $6.41
  • Average True Range (ATR)
  • VRAX 0.25
  • REBN 1.08
  • MACD
  • VRAX 0.01
  • REBN 0.01
  • Stochastic Oscillator
  • VRAX 47.88
  • REBN 48.59

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Share on Social Networks: